GIOVANNA GALLO

Dottoressa di ricerca

ciclo: XXXIV



Titolo della tesi: Investigation of the molecular mechanisms underlying left ventricular hypertrophy in the presence of Complex I deficiency-dependent mitochondrial dysfunction

Several studies have demonstrated that a dysfunction of the mitochondrial Complex I (CI) and of the sirtuins pathway is associated with the development of left ventricular hypertrophy (LVH). A deficiency of Ndufc2 (a subunit of NADH dehydrogenase [ubiquinone]) has been previously shown to cause an altered CI activity with severe mitochondrial dysfunction. We examined the role of Ndufc2 deficiency and of subsequent CI dysfunction on the development of cardiac hypertrophy both in an in-vitro model and in humans. We performed Ndufc2 gene silencing in H9c2 cardiomyocytes. We found that Ndufc2-silenced cardiomyocytes, compared to not silenced cells, showed a significant degree of hypertrophy by fluorescence microscopy (p<0.01), with a significant increase of the hypertrophy markers ANP and beta-myosin heavy chain (p<0.01). In parallel, sirtuin 3 and its downstream molecules (AMPK, phosphoAMPK, FOXO3a) were significantly reduced (p<0.05), with an increase of the mTOR pathway (p<0.05). The administration of nicotinamide, restoring CI function, was able to reduce the cellular volume and the gene expression level of both hypertrophy markers. We confirmed these results also in rat neonatal cardiomyocytes. With regard to the human study, we included 232 hypertensive subjects (136 male, 58.6%) with a mean age of 59 ± 15 years. Seventy-five individuals (32%) presented LVH. The analysis of possible associations with echocardiographic parameters showed that hypertensive patients who were carriers of the mutant A allele at NDUFC2 rs641836 had a significantly increase in septal thickness, posterior wall thickness, relative wall thickness (RWT), LV mass, LV mass/body surface area (BSA) and LV mass/height2.7 compared to wild-type homozygotes. With regard to the NDUFC2 rs11237379 polymorphism, hypertensive patients who were carriers of the TT genotype had a significantly increase in septal thickness, posterior wall thickness, RWT and LV mass/BSA compared to subjects who were carriers of both the CC genotype and CT genotype.

Produzione scientifica

  • 11573/871355 - 2016 - Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease (01a Articolo in rivista)
    GALLO, GIOVANNA; SALERNO, GERARDO; VOLPE, MASSIMO; DE BIASE, LUCIANO
  • 11573/1060934 - 2018 - Is early and fast blood pressure control important in hypertension management? (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; TOCCI, GIULIANO
  • 11573/1014863 - 2017 - Aspirin and the Primary Prevention of Cardiovascular Diseases. An Approach Based on Individualized, Integrated Estimation of Risk (01a Articolo in rivista)
    VOLPE, MASSIMO; BATTISTONI, ALLEGRA; GALLO, GIOVANNA; COLUCCIA, ROBERTA
  • 11573/1112014 - 2017 - Recurrence of acute coronary syndrome during inadeguate control of cardiovascular risk factors (01h Abstract in rivista)
    SIMONELLI, FRANCESCA; ABBOLITO, SOFIA; MIOTTI, CRISTIANO; GALLO, GIOVANNA; BUROCCHI, SIMONE; VOLPE, MASSIMO; DE BIASE, LUCIANO
  • 11573/1111972 - 2018 - Role of oxidative stress in the process of vascular remodeling following coronary revascularization. (01a Articolo in rivista)
    GALLO, GIOVANNA; COLUCCIA, ROBERTA; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1112018 - 2017 - Gender differences in acute coronary syndromes: Do they count? (04c Atto di convegno in rivista)
    ABBOLITO, SOFIA; MIOTTI, CRISTIANO; BUROCCHI, SIMONE; GALLO, GIOVANNA; SALERNO, GERARDO; SIMONELLI, FRANCESCA; VOLPE, MASSIMO; DE BIASE, LUCIANO
  • 11573/1112024 - 2017 - Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH) (01h Abstract in rivista)
    SIMONELLI, FRANCESCA; MIOTTI, CRISTIANO; GALLO, GIOVANNA; BUROCCHI, SIMONE; SALERNO, GERARDO; ABBOLITO, SOFIA; VOLPE, MASSIMO; DE BIASE, LUCIANO
  • 11573/1112702 - 2017 - Potential impact of statin use on day-time and night-time blood pressure levels: a retrospective analysis of a large database of 24-hour ambulatory blood pressure monitoring (04c Atto di convegno in rivista)
    TOCCI, GIULIANO; PRESTA, VIVIANNE; FIGLIUZZI, ILARIA; COSTANZI, VIVIANA; GALLO, GIOVANNA; ATTALLA ELHALABIEH, NADIA; SIMONELLI, FRANCESCA; CITONI, BARBARA; BATTISTONI, ALLEGRA; FERRUCCI, ANDREA; VOLPE, MASSIMO
  • 11573/1112708 - 2017 - Prevalence and clinical characteristics of true masked hypertension compared to reverse and isolated nocturnal masked hypertension (04c Atto di convegno in rivista)
    TOCCI, GIULIANO; ATTALLA ELHALABIEH, NADIA; SIMONELLI, FRANCESCA; PRESTA, VIVIANNE; FIGLIUZZI, ILARIA; GALLO, GIOVANNA; COSTANZI, VIVIANA; CITONI, BARBARA; BATTISTONI, ALLEGRA; FERRUCCI, ANDREA; VOLPE, MASSIMO
  • 11573/1112706 - 2017 - Comparison among different electrocardiographic criteria for left ventricular hypertrophy: retrospective analysis of a large cohort of adult outpatients with hypertension (04c Atto di convegno in rivista)
    TOCCI, GIULIANO; COSTANZI, VIVIANA; GALLO, GIOVANNA; SIMONELLI, FRANCESCA; ATTALLA ELHALABIEH, NADIA; FIGLIUZZI, ILARIA; PRESTA, VIVIANNE; CITONI, BARBARA; BATTISTONI, ALLEGRA; FERRUCCI, ANDREA; VOLPE, MASSIMO
  • 11573/1112710 - 2017 - Prevalence and clinical outcomes of white coat and masked hypertension compared to normotension and sustained hypertension. (04c Atto di convegno in rivista)
    TOCCI, GIULIANO; SIMONELLI, FRANCESCA; ATTALLA ELHALABIEH, NADIA; D'AGOSTINO, MICHELA; PRESTA, VIVIANNE; FIGLIUZZI, ILARIA; GALLO, GIOVANNA; COSTANZI, VIVIANA; CITONI, BARBARA; BATTISTONI, ALLEGRA; FERRUCCI, ANDREA; VOLPE, MASSIMO
  • 11573/1211239 - 2019 - Highlights of ESC/ESH 2018 guidelines on the management of hypertension. what every doctor Should Know (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; BATTISTONI, ALLEGRA; TOCCI, GIULIANO
  • 11573/1190901 - 2019 - The “hidden side of the moon” in hypertension. When and why is dangerous low diastolic blood pressure? (01m Editorial/Introduzione in rivista)
    VOLPE, MASSIMO; BATTISTONI, ALLEGRA; GALLO, GIOVANNA; CARNEVALE, DANIELA
  • 11573/1259776 - 2019 - The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome (01a Articolo in rivista)
    RAFFA, SALVATORE; MICALONI, ANDREA; GALLO, GIOVANNA; SCHIRONE, LEONARDO; TOCCI, GIULIANO; TORRISI, MARIA ROSARIA; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1259903 - 2019 - Molecular and clinical implications of natriuretic peptides in aortic valve stenosis (01a Articolo in rivista)
    GALLO, GIOVANNA; PRESTA, VIVIANNE; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1271128 - 2019 - Novel blood pressure targets in patients with high-normal levels and grade 1 hypertension. room for monotherapy? (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; TOCCI, GIULIANO
  • 11573/1271122 - 2019 - Implications of guidelines for hypertension management in europe. (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; BATTISTONI, ALLEGRA; TOCCI, GIULIANO
  • 11573/1195040 - 2018 - Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes (01a Articolo in rivista)
    COLUCCIA, ROBERTA; RAFFA, SALVATORE; RANIERI, DANILO; MICALONI, ANDREA; VALENTE, SABATINO; SALERNO, GERARDO; SCROFANI, CRISTINA; GALLO, GIOVANNA; PAGANNONE, ERIKA; TORRISI, MARIA ROSARIA; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1330456 - 2019 - Legacy effect in the treatment of hypertension: persistent cardiovascular protection after conclusion of randomized clinical trials in hypertension (01a Articolo in rivista)
    GALLO, GIOVANNA; BATTISTONI, ALLEGRA; COLUCCIA, ROBERTA; TOCCI, GIULIANO; VOLPE, MASSIMO
  • 11573/871369 - 2016 - Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease (01a Articolo in rivista)
    SALERNO, GERARDO; VOLPE, MASSIMO; DE BIASE, LUCIANO; GALLO, GIOVANNA; PANEBIANCO, MARIO; ABBOLITO, SOFIA; GALLO, GIOVANNA
  • 11573/871369 - 2016 - Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease (01a Articolo in rivista)
    SALERNO, GERARDO; VOLPE, MASSIMO; DE BIASE, LUCIANO; GALLO, GIOVANNA; PANEBIANCO, MARIO; ABBOLITO, SOFIA; GALLO, GIOVANNA
  • 11573/1341610 - 2019 - Aspirin in primary prevention. 'nothing else matters' … like hypertension (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1386828 - 2018 - Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy (01a Articolo in rivista)
    VOLPE, MASSIMO; BATTISTONI, ALLEGRA; GALLO, GIOVANNA; RUBATTU, SPERANZA DONATELLA; TOCCI, GIULIANO; SALVETTI, GIULIA; TRIMARCO, BARBARA
  • 11573/1398970 - 2020 - Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation (01a Articolo in rivista)
    GALLO, GIOVANNA; STANZIONE, ROSITA; COTUGNO, ENRICO MARIA; MARCHITTI, SIMONA; BERNI, ANDREA; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/965721 - 2017 - 2017 Position paper of the italian society for cardiovascular prevention (SIPREC) for an updated clinical management of hypercholesterolemia and cardiovascular risk: executive document (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; PRESTA, VIVIANNE; TOCCI, GIULIANO
  • 11573/1400056 - 2020 - Cardiovascular death risk in recovered mid-range ejection fraction heart failure. insights from cardiopulmonary exercise test (01a Articolo in rivista)
    MAGRI', DAMIANO; GALLO, GIOVANNA; MARUOTTI, ANTONELLO; METRA, MARCO; GUAZZI, MARCO; BADAGLIACCA, ROBERTO; SCIOMER, SUSANNA; VOLPE, MASSIMO
  • 11573/1403890 - 2020 - Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing (01a Articolo in rivista)
    MAGRI', DAMIANO; MASTROMARINO, VITTORIA; GALLO, GIOVANNA; GIORDANO, DARIO; RUBATTU, SPERANZA DONATELLA; COTUGNO, ENRICO MARIA; TORRISI, MARIA ROSARIA; PETRUCCI, SIMONA; GERMANI, ALDO; MARUOTTI, ANTONELLO; VOLPE, MASSIMO; AUTORE, CAMILLO; PIANE, MARIA; MUSUMECI, MARIA BEATRICE
  • 11573/1424306 - 2020 - Blockade of the neurohormonal systems in heart failure with preserved ejection fraction. A contemporary meta-analysis (01a Articolo in rivista)
    GALLO, GIOVANNA; TOCCI, GIULIANO; BATTISTONI, ALLEGRA; RUBATTU, SPERANZA DONATELLA; VOLPE, MASSIMO
  • 11573/1432684 - 2020 - Natriuretic Peptides, Cognitive Impairment and Dementia. An Intriguing Pathogenic Link with Implications in Hypertension (01g Articolo di rassegna (Review))
    GALLO, GIOVANNA; COTUGNO, ENRICO MARIA; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1364182 - 2020 - Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction (01a Articolo in rivista)
    MAGRI', DAMIANO; MAPELLI, MICHELA; GALLO, GIOVANNA; BONOMI, ALDO; LIMONGELLI, GIORGIO; METRA, MARCO; PICCIOLI, LUCA; CARAVITA, SIMONA CARLA SILVIA; GUAZZI, MARCO; BADAGLIACCA, ROBERTO; SCIOMER, SUSANNA
  • 11573/1469891 - 2020 - Markers of cardiotoxicity in early breast cancer patients treated with a hypofractionated schedule. A prospective study (01a Articolo in rivista)
    DE SANCTIS, VITALIANA; ALFO', MARCO; VITIELLO, CECILIA; VULLO, GIANLUCA; FACONDO, GIUSEPPE; MARINELLI, LORENZO; BUROCCHI, SIMONE; GALLO, GIOVANNA; RUSSO, IVANA; SALERNO, GERARDO; CARDELLI, PATRIZIA; OSTI, MATTIA FALCHETTO; DE BIASE, LUCIANO
  • 11573/1469886 - 2020 - Sacubitril/valsartan for the management of heart failure. A perspective viewpoint on current evidence (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; BATTISTONI, ALLEGRA
  • 11573/1469880 - 2020 - Sacubitril/Valsartan. Potential Impact of ARNi "Beyond the Wall" of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 (01a Articolo in rivista)
    RUBATTU, SPERANZA DONATELLA; GALLO, GIOVANNA; VOLPE, MASSIMO
  • 11573/1469876 - 2021 - Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists (01m Editorial/Introduzione in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1469871 - 2020 - New approach to blood pressure control. Triple combination pill (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; TOCCI, GIULIANO
  • 11573/1469865 - 2020 - Risk stratification in heart failure with mild reduced ejection fraction. European Journal of Preventive Cardiology (01g Articolo di rassegna (Review))
    MAGRI', DAMIANO; GALLO, GIOVANNA
  • 11573/1469862 - 2020 - Systolic blood pressure target less than 120 mmHg. the 'Chariot Allegory' in hypertension? (01m Editorial/Introduzione in rivista)
    GALLO, GIOVANNA; VOLPE, MASSIMO
  • 11573/1469858 - 2020 - To whom recommend intensive treatment for hypertension? (01a Articolo in rivista)
    GALLO, GIOVANNA; VOLPE, MASSIMO
  • 11573/1469855 - 2020 - Atrial fibrillation and ischaemic heart disease. should we use acetylsalicylic acid beside anticoagulants? (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1469893 - 2018 - Dyslipidaemia In Hypertension (02a Capitolo o Articolo)
    VOLPE, MASSIMO; GALLO, GIOVANNA; TOCCI, GIULIANO
  • 11573/1469888 - 2020 - COVID-19 and the Forgotten Majority (01m Editorial/Introduzione in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1658905 - 2022 - Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set (01a Articolo in rivista)
    GALLO, GIOVANNA; METRA, MARCO; MARUOTTI, ANTONELLO; BADAGLIACCA, ROBERTO; SCIOMER, SUSANNA
  • 11573/1540985 - 2021 - Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company (01a Articolo in rivista)
    GALLO, GIOVANNA; VOLPE, MASSIMO
  • 11573/1517483 - 2021 - ARB-based combination therapy for the clinical management of hypertension and hypertension-related comorbidities: a spotlight on their use in COVID-19 patients (01g Articolo di rassegna (Review))
    PRESTA, VIVIANNE; FIGLIUZZI, ILARIA; CITONI, BARBARA; GALLO, GIOVANNA; BATTISTONI, ALLEGRA; TOCCI, GIULIANO; VOLPE, MASSIMO
  • 11573/1547847 - 2021 - A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment (01f Lettera, Nota)
    TINI, GIACOMO; GALLO, GIOVANNA; MUSUMECI, MARIA BEATRICE; TOCCI, GIULIANO; VOLPE, MASSIMO
  • 11573/1547823 - 2021 - Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy (01a Articolo in rivista)
    GALLO, GIOVANNA; MUSUMECI, MARIA BEATRICE; AUTORE, CAMILLO; MAGRI', DAMIANO
  • 11573/1572891 - 2021 - Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum (01a Articolo in rivista)
    GALLO, GIOVANNA; VOLPE, MASSIMO; BATTISTONI, ALLEGRA; RUSSO, DOMITILLA; TOCCI, GIULIANO; MUSUMECI, MARIA BEATRICE
  • 11573/1572907 - 2021 - Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension. one shot for a double strike? (01m Editorial/Introduzione in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1575967 - 2021 - Are post-hoc analyses on subgroups sufficient to support new treatment algorithms of heart failure? The case of SGLT2 inhibitors associated with sacubitril/valsartan (01f Lettera, Nota)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1585141 - 2021 - Novel ANP (Atrial Natriuretic Peptide) based therapy for hypertension: the promising role of a disease mechanism targeted approach (01m Editorial/Introduzione in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; RUBATTU, SPERANZA DONATELLA
  • 11573/1585143 - 2022 - The natriuretic peptides for hypertension treatment (01g Articolo di rassegna (Review))
    RUBATTU, SPERANZA DONATELLA; GALLO, GIOVANNA
  • 11573/1585146 - 2021 - Targeting cyclic guanylate monophosphate in resistant hypertension and heart failure. Are sacubitril/valsartan and vericiguat synergistic and effective in both conditions? (01m Editorial/Introduzione in rivista)
    GALLO, GIOVANNA; RUBATTU, SPERANZA DONATELLA; VOLPE, MASSIMO
  • 11573/1613028 - 2022 - Hypertension and COVID-19. Current Evidence and Perspectives (01g Articolo di rassegna (Review))
    GALLO, GIOVANNA; CALVEZ, VALENTIN; SAVOIA, CARMINE
  • 11573/1612992 - 2022 - Endothelial Dysfunction in Hypertension. Current Concepts and Clinical Implications (01g Articolo di rassegna (Review))
    GALLO, GIOVANNA; VOLPE, MASSIMO; SAVOIA, CARMINE
  • 11573/1628865 - 2022 - Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy (01a Articolo in rivista)
    MAGRI', DAMIANO; GALLO, GIOVANNA; SCLAFANI, MATTEO; AUTORE, CAMILLO
  • 11573/1627551 - 2022 - Investigation of the molecular mechanisms underlying left ventricular hypertrophy in the presence of Complex I deficiency-dependent mitochondrial dysfunction (07a Tesi di Dottorato)
    GALLO, GIOVANNA
  • 11573/1632275 - 2022 - Relationship Between Cardiorespiratory Fitness, Baseline Blood Pressure and Hypertensive Response to Exercise in the Ferrari Corporate Population (01a Articolo in rivista)
    GALLO, GIOVANNA; VOLPE, MASSIMO
  • 11573/1642948 - 2022 - Impact of a NDUFC2 Variant on the Occurrence of Acute Coronary Syndromes (01a Articolo in rivista)
    GALLO, GIOVANNA; COTUGNO, ENRICO MARIA; STANZIONE, ROSITA; MARCHITTI, SIMONA; AUTORE, CAMILLO; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1649344 - 2022 - Myocardial Infarction in Patients Without Cardiovascular Risk Factors. Advanced Prediction Models to Unlock the Clinical Dilemma? (01m Editorial/Introduzione in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA
  • 11573/1663474 - 2022 - Endocrine functions of the heart: from bench to bedside (01a Articolo in rivista)
    VOLPE, MASSIMO; GALLO, GIOVANNA; RUBATTU, SPERANZA DONATELLA
  • 11573/1649766 - 2022 - β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality (01g Articolo di rassegna (Review))
    CORRADETTI, SARA; GALLO, GIOVANNA; BADAGLIACCA, ROBERTO; MAGRI', DAMIANO
  • 11573/1674151 - 2023 - New insight in cardiorenal syndrome: from biomarkers to therapy (01a Articolo in rivista)
    GALLO, GIOVANNA; LANZA, ORESTE; SAVOIA, CARMINE
  • 11573/1662772 - 2021 - [Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy] (01a Articolo in rivista)
    BATTISTONI, ALLEGRA; GALLO, GIOVANNA; CORSINI, ALBERTO; GALIUTO, LEONARDA; INDOLFI, CIRO; NATI, GIULIO; RUBATTU, SPERANZA DONATELLA; SERDOZ, ANDREA; SQUEO, MARIA ROSARIA; TOCCI, GIULIANO; VOLPE, MASSIMO
  • 11573/1659066 - 2022 - Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination (01a Articolo in rivista)
    CORRADETTI, SARA; SCLAFANI, MATTEO; MISTRULLI, RAFFAELLA; GALLO, GIOVANNA; PAGANNONE, ERIKA; DI GIROLAMO, MARCO; AUTORE, CAMILLO; BATTISTONI, ALLEGRA; VOLPE, MASSIMO
  • 11573/1112704 - 2017 - Comparison between european systematic coronary risk evaluation and italian cuore algorithms in adult outpatients followed by general practitioners and specialised centres (01h Abstract in rivista)
    TOCCI, GIULIANO; GALLO, GIOVANNA; COSTANZI, VIVIANA; ATTALLA ELHALABIEH, NADIA; SIMONELLI, FRANCESCA; PRESTA, VIVIANNE; FIGLIUZZI, ILARIA; CITONI, BARBARA; BATTISTONI, ALLEGRA; FERRUCCI, ANDREA; VOLPE, MASSIMO
  • 11573/1111983 - 2018 - Use of fixed-dose combinations in hypertension and cardiovascular disease prevention (02a Capitolo o Articolo)
    VOLPE, MASSIMO; TOCCI, GIULIANO; GALLO, GIOVANNA
  • 11573/1554291 - 2021 - Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy. (01a Articolo in rivista)
    MAGRI', DAMIANO; GALLO, GIOVANNA
  • 11573/1651593 - 2022 - Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations (01a Articolo in rivista)
    GALLO, GIOVANNA; VOLPE, MASSIMO; RUBATTU, SPERANZA DONATELLA
  • 11573/1564997 - 2021 - A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era (01a Articolo in rivista)
    RUBATTU, SPERANZA DONATELLA; GALLO, GIOVANNA; VOLPE, MASSIMO

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma